Therapeutic Asset Ratings
159 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
FILGRASTIM
Fanconi Anemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
BBB
(74)
Monomethyl Fumarate
Fanconi Anemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2/3
BBB
(74)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Bone Marrow Failure
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2/3
BB
(69)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Fanconi Anemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2/3
BB
(69)
Enzalutamide
Hormone-Resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P3
BB
(68)
TACROLIMUS
Fanconi Anemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
BB
(68)
Cyclophosphamide
Immunodeficiencies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
BB
(67)
Evomela
Fanconi Anemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
BB
(66)
Evomela
Immunodeficiencies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
BB
(66)
FILGRASTIM
Immunodeficiencies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
BB
(65)
Fludarabine
Immunodeficiencies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
BB
(65)
TACROLIMUS
Carcinoma, Hepatocellular
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P4
BB
(64)
DEXAMETHASONE
Metastatic Castration-Resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P4
B
(63)
Evomela
Metastatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P3
B
(63)
Evomela
Bone Marrow Failure
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(63)
Nivolumab
Fibrolamellar Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(63)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Immunodeficiencies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(62)
TESTOSTERONE ENANTATE
Castration Resistant Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(62)
TESTOSTERONE UNDECYLATE
Castration-Resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(61)
Cyclophosphamide
Immune Deficiency Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(60)
GVAX
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(60)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Immune Deficiency Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(60)
Retifanlimab
Pancreatic Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(60)
Bet Bromodomain Inhibitor Zen-3694
Metastatic Castration-Resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(59)
Gvax Pancreas Vaccine
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
B
(59)
Showing 1 to 25 of 159 assets
Previous
Page 1 of 7
Next